Nirsevimab Effectiveness Against Medically Attended Respiratory Syncytial Virus Illness and Hospitalization Among Alaska Native Children - Yukon-Kuskokwim Delta Region, Alaska, October 2023-June 2024

Published on November 14, 2024

This report describes nirsevimab effectiveness in preventing RSV-associated hospitalizations among children in Alaska's Yukon-Kuskokwim Delta region.